• Advancing NAMs for In Vitro Skin Sensitization Testing

    Top reasons customers test with us: scientific expertise and personal support

    Test with us - get a quote
    In vitro skin sensitization testing services at SenzaGen

GARD®skin: OECD 442E

In vitro skin sensitization testing
powered by genomics and machine learning.
EXPLORE MORE

Do you have “difficult-to-test” samples?

UVCBs, Natural Extracts, Formulations and more.
LEARN MORE

Trusted by industry leaders

Cargill

Joint poster on Hydrophobic Esters

Corteva Agriscience

Joint publication on Agrochemical Formulations

ExxonMobil

Joint poster on UVCBs and Formulated Lubricant Products

L’Oréal

Joint publication on Skin Sensitization Potency Assessment

Sonova

Joint poster on Medical Devices
WHO WE WORK WITH

Join a thriving scientific community of skin sensitization

– and never miss our latest webinars and insights

SIGN UP FOR UPDATES

Meet us

EVENT CALENDAR
In vitro skin sensitization expert Andy presenting at ESTIV

Dr Andy Forreryd, Skin Sensitization Expert at SenzaGen, presenting at ESTIV about GARD®

Press Releases

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
22 Apr, 2025
News
IR
English
Corporate Information
Other Corporate Information
FDA signals shift towards non-animal testing in the pharmaceutical industry – strengthens SenzaGen’s commercial potential
11 Apr, 2025
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice of Annual General Meeting of SenzaGen AB (publ)
11 Apr, 2025
News
IR
English
Regulatory
Listing Regulation
Report
Annual
SenzaGen’s Annual Report 2024 published
Next

News Posts

Subscribe


Prenumerera